Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

1.

The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy.

Neugut AI, Hillyer GC, Kushi LH, Lamerato L, Nathanson SD, Ambrosone CB, Bovbjerg DH, Mandelblatt JS, Magai C, Tsai WY, Jacobson JS, Hershman DL.

Breast J. 2012 May-Jun;18(3):203-13. doi: 10.1111/j.1524-4741.2012.01240.x. Epub 2012 Apr 5.

PMID:
22487337
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024
[PubMed - indexed for MEDLINE]
Free Article
3.

Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL).

Neugut AI, Hillyer GC, Kushi LH, Lamerato L, Leoce N, Nathanson SD, Ambrosone CB, Bovbjerg DH, Mandelblatt JS, Magai C, Tsai WY, Jacobson JS, Hershman DL.

Breast Cancer Res Treat. 2012 Jul;134(1):419-28. doi: 10.1007/s10549-012-2066-9. Epub 2012 Apr 22.

PMID:
22527111
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.

Mariotto AB, Feuer EJ, Harlan LC, Abrams J.

J Natl Cancer Inst Monogr. 2006;(36):7-15.

PMID:
17032888
[PubMed - indexed for MEDLINE]
5.

Adjuvant therapy for breast cancer.

[No authors listed]

NIH Consens Statement. 2000 Nov 1-3;17(4):1-35. Review.

PMID:
11512506
[PubMed - indexed for MEDLINE]
6.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
7.

Can differences in breast cancer utilities explain disparities in breast cancer care?

Schleinitz MD, DePalo D, Blume J, Stein M.

J Gen Intern Med. 2006 Dec;21(12):1253-60. Epub 2006 Sep 1.

PMID:
16961753
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Adjuvant hormonal therapy use among insured, low-income women with breast cancer.

Kimmick G, Anderson R, Camacho F, Bhosle M, Hwang W, Balkrishnan R.

J Clin Oncol. 2009 Jul 20;27(21):3445-51. doi: 10.1200/JCO.2008.19.2419. Epub 2009 May 18.

PMID:
19451445
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

PMID:
16959170
[PubMed - indexed for MEDLINE]
Free Article
10.

Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative.

Livaudais JC, Lacroix A, Chlebowski RT, Li CI, Habel LA, Simon MS, Thompson B, Erwin DO, Hubbell FA, Coronado GD.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):365-73. doi: 10.1158/1055-9965.EPI-12-1225. Epub 2012 Dec 28.

PMID:
23275187
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A systematic overview of chemotherapy effects in breast cancer.

Bergh J, J├Ânsson PE, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):253-81. Review.

PMID:
11441936
[PubMed - indexed for MEDLINE]
12.

Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women.

Dignam JJ.

J Natl Cancer Inst Monogr. 2001;(30):36-43.

PMID:
11773290
[PubMed - indexed for MEDLINE]
13.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG).

Lancet. 2005 May 14-20;365(9472):1687-717.

PMID:
15894097
[PubMed - indexed for MEDLINE]
14.

Noninitiation of adjuvant chemotherapy in women with localized breast cancer: the breast cancer quality of care study.

Neugut AI, Hillyer GC, Kushi LH, Lamerato L, Leoce N, Nathanson SD, Ambrosone CB, Bovbjerg DH, Mandelblatt JS, Magai C, Tsai WY, Jacobson JS, Hershman DL.

J Clin Oncol. 2012 Nov 1;30(31):3800-9. doi: 10.1200/JCO.2012.43.8168. Epub 2012 Sep 24.

PMID:
23008305
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.

International Breast Cancer Study Group (IBCSG), Castiglione-Gertsch M, O'Neill A, Price KN, Goldhirsch A, Coates AS, Colleoni M, Nasi ML, Bonetti M, Gelber RD.

J Natl Cancer Inst. 2003 Dec 17;95(24):1833-46.

PMID:
14679153
[PubMed - indexed for MEDLINE]
Free Article
16.

Understanding discontinuation of oral adjuvant endocrine therapy by women with hormone receptor-positive invasive breast cancer nearly 4 years from diagnosis.

Bell RJ, Fradkin P, Schwarz M, Davis SR.

Menopause. 2013 Jan;20(1):15-21. doi: 10.1097/gme.0b013e3182610cab.

PMID:
22948136
[PubMed - indexed for MEDLINE]
17.

Impact of race and ethnicity on outcomes for estrogen receptor-negative breast cancers: experience of an academic center with a charity hospital.

Chu QD, Burton G, Glass J, Smith MH, Li BD.

J Am Coll Surg. 2010 May;210(5):585-92, 592-4. doi: 10.1016/j.jamcollsurg.2010.01.025.

PMID:
20421009
[PubMed - indexed for MEDLINE]
18.

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

[No authors listed]

Lancet. 1998 May 16;351(9114):1451-67.

PMID:
9605801
[PubMed - indexed for MEDLINE]
19.

Missed opportunities: racial disparities in adjuvant breast cancer treatment.

Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, Mendez J, Guth AA.

J Clin Oncol. 2006 Mar 20;24(9):1357-62.

PMID:
16549830
[PubMed - indexed for MEDLINE]
Free Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk